Shiffman ML - Search Results

1

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.

Wilder JM, Jeffers LJ, Ravendhran N, Shiffman ML, Poulos J, Sulkowski MS, Gitlin N, Workowski K, Zhu Y, Yang JC, Pang PS, McHutchison JG, Muir AJ, Howell C, Kowdley K, Afdhal N, Reddy KR. Wilder JM, et al. Among authors: shiffman ml. Hepatology. 2016 Feb;63(2):437-44. doi: 10.1002/hep.28334. Epub 2015 Dec 18. Hepatology. 2016. PMID: 26547499 Free PMC article. Clinical Trial.

2

The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board.

Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. Shiffman ML, et al. Hepatology. 1995 Nov;22(5):1591-7. Hepatology. 1995. PMID: 7590680 Review.

3

Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.

Shiffman ML, Luketic VA, Sanyal AJ, Duckworth PF, Purdum PP 3rd, Contos MJ, Mills AS, Edinboro LE, Poklis A. Shiffman ML, et al. Hepatology. 1994 Apr;19(4):933-40. Hepatology. 1994. PMID: 8138268

4

Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose.

Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ, Contos MJ, Mills AS. Shiffman ML, et al. Hepatology. 1996 Jul;24(1):21-6. doi: 10.1002/hep.510240105. Hepatology. 1996. PMID: 8707264 Clinical Trial.

5

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

Shiffman ML, Hofmann CM, Thompson EB, Ferreira-Gonzalez A, Contos MJ, Koshy A, Luketic VA, Sanyal AJ, Mills AS, Garrett CT. Shiffman ML, et al. Hepatology. 1997 Sep;26(3):780-5. doi: 10.1002/hep.510260335. Hepatology. 1997. PMID: 9303513

6

Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C.

Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ. Shiffman ML, et al. J Hepatol. 1998 Mar;28(3):382-9. doi: 10.1016/s0168-8278(98)80310-3. J Hepatol. 1998. PMID: 9551674 Clinical Trial.

7

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. McHutchison JG, et al. Among authors: shiffman ml. N Engl J Med. 1998 Nov 19;339(21):1485-92. doi: 10.1056/NEJM199811193392101. N Engl J Med. 1998. PMID: 9819446 Free article. Clinical Trial.

8

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

Lindsay KL, Trepo C, Heintges T, Shiffman ML, Gordon SC, Hoefs JC, Schiff ER, Goodman ZD, Laughlin M, Yao R, Albrecht JK; Hepatitis Interventional Therapy Group. Lindsay KL, et al. Among authors: shiffman ml. Hepatology. 2001 Aug;34(2):395-403. doi: 10.1053/jhep.2001.26371. Hepatology. 2001. PMID: 11481625 Clinical Trial.

9

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Fried MW, et al. Among authors: shiffman ml. N Engl J Med. 2002 Sep 26;347(13):975-82. doi: 10.1056/NEJMoa020047. N Engl J Med. 2002. PMID: 12324553 Free article. Clinical Trial.

10

Retreatment of patients with chronic hepatitis C.

Shiffman ML. Shiffman ML. Hepatology. 2002 Nov;36(5 Suppl 1):S128-34. doi: 10.1053/jhep.2002.36816. Hepatology. 2002. PMID: 12407586 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page